News

Cognition Therapeutics, Inc. (CGTX) Description, Stock price, News & Info.

By ThinkSabio

#ThinkSabio Latest News

Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy

By ThinkSabio

Related Post

News

Sonnet BioTherapeutics Holdings, Inc. (SONN) Description, Stock price, News & Info.

ThinkSabio
News

SolarEdge Technologies, Inc. (SEDG) Description, Stock price, News & Info.

ThinkSabio
News

N2OFF, Inc. (NITO) Description, Stock price, News & Info.

ThinkSabio

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

News

Sonnet BioTherapeutics Holdings, Inc. (SONN) Description, Stock price, News & Info.

News

SolarEdge Technologies, Inc. (SEDG) Description, Stock price, News & Info.

News

N2OFF, Inc. (NITO) Description, Stock price, News & Info.

News

Eli Lilly and Company (LLY) Description, Stock price, News & Info.